US 8580748
Peptides for the treatment of hearing
granted A61KA61K38/10A61K38/162
Quick answer
US patent 8580748 (Peptides for the treatment of hearing) held by Compass Therapeutics LLC expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 102
- CPC classes
- A61K, A61K38/10, A61K38/162, A61K9/0046, A61P